Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs

References

• Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems – an overview. Acta Pharm Sin B. 2013;3(6):361–372.
   Web of Science ®Google Scholar
• Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3–4):278–287.
   PubMed Web of Science ®Google Scholar
• Ashkar A, Sosnik A, Davidovich-Pinhas M. Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv. 2021;54:107789.
   PubMed Web of Science ®Google Scholar
• Cole ET, Cade D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60(6):747–756.
   PubMed Web of Science ®Google Scholar
• Chauhan G, Shaik AA, Kulkarni NS, et al. The preparation of lipid-based drug delivery system using melt extrusion. Drug Discov Today. 2020;25(11):1930–1943.
   Web of Science ®Google Scholar
• Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625–637.
   PubMed Web of Science ®Google Scholar
• Wang HH, Portincasa P, Wang DQ. Update on the molecular mechanisms underlying the effect of cholecystokinin and cholecystokinin-1 receptor on the formation of cholesterol gallstones. Curr Med Chem. 2019;26(19):3407–3423.
   PubMed Web of Science ®Google Scholar
• Amara S, Bourlieu C, Humbert L, et al. Variations in gastrointestinal lipases, pH and bile acid levels with food intake, age and diseases: possible impact on oral lipid-based drug delivery systems. Adv Drug Deliv Rev. 2019;142:3–15.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Mishra B, et al. Lipid–an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 2009;73(1):1–15.
   PubMed Web of Science ®Google Scholar
• Park M-J, Balakrishnan P, Yang S-G. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int J Pharm. 2013;441(1):757–764.
   PubMedGoogle Scholar
• AboulFotouh K, Allam AA, El-Badry M, et al. Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability. Colloids Surf B Biointerfaces. 2018;167:82–92.
   PubMed Web of Science ®Google Scholar
• Vithani K, Jannin V, Pouton CW, et al. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs. Adv Drug Deliv Rev. 2019;142:16–34.
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25(1):47–58.
   Web of Science ®Google Scholar
• Chatterjee B, Hamed Almurisi S, Ahmed Mahdi Dukhan A, et al. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view. Drug Deliv. 2016;23(9):3639–3652.
   PubMed Web of Science ®Google Scholar
• Rani S, Rana R, Saraogi GK, et al. Self-Emulsifying oral lipid drug delivery systems: advances and challenges. AAPS PharmSciTech. 2019;20(3):129.
   PubMed Web of Science ®Google Scholar
• Agrawal AG, Kumar A, Gide PS. Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide. Colloids Surf B Biointerfaces. 2015;126:553–560.
   PubMed Web of Science ®Google Scholar
• Salawi A. Self-emulsifying drug delivery systems: a novel approach to deliver drugs. Drug Deliv. 2022;29(1):1811–1823.
   PubMed Web of Science ®Google Scholar
• Sun C, Gui Y, Hu R, et al. Preparation and pharmacokinetics evaluation of solid self-microemulsifying drug delivery system (S-SMEDDS) of osthole. AAPS PharmSciTech. 2018;19(5):2301–2310.
   PubMed Web of Science ®Google Scholar
• Borkar N, Mu H, Holm R. Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson’s disease. Asian J Pharm Sci. 2018;13(6):507–517.
   PubMed Web of Science ®Google Scholar
• Mishra V, Nayak P, Yadav N, et al. Orally administered self-emulsifying drug delivery system in disease management: advancement and patents. Expert Opin Drug Deliv. 2021 Mar;18(3):315–332.
   Web of Science ®Google Scholar
• Leonaviciute G, Bernkop-Schnürch A. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery. Expert Opin Drug Deliv. 2015;12(11):1703–1716.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Ukai H, Morishita M, et al. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs. Pharmacol Ther. 2020;211:107537.
   PubMed Web of Science ®Google Scholar
• Gamboa A, Schüßler N, Soto-Bustamante E, et al. Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids. Eur J Pharm Biopharm. 2020;156:203–218.
   PubMed Web of Science ®Google Scholar
• Nazir I, Asim MH, Dizdarevic A, et al. Self-emulsifying drug delivery systems: impact of stability of hydrophobic ion pairs on drug release. Int J Pharm. 2019;561:197–205.
   PubMedGoogle Scholar
• Lu HD, Rummaneethorn P, Ristroph KD, et al. Hydrophobic ion pairing of peptide antibiotics for processing into controlled release nanocarrier formulations. Mol Pharm. 2018;15(1):216–225.
   PubMedGoogle Scholar
• Phan TNQ, Shahzadi I, Bernkop-Schnürch A. Hydrophobic ion-pairs and lipid-based nanocarrier systems: the perfect match for delivery of BCS class 3 drugs. J Control Release. 2019;304:146–155.
   PubMed Web of Science ®Google Scholar
• Hauptstein S, Prüfert F, Bernkop-Schnürch A. Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Int J Pharm. 2015;487(1–2):25–31.
   PubMedGoogle Scholar
• Hintzen F, Perera G, Hauptstein S, et al. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm. 2014;472(1–2):20–26.
   PubMed Web of Science ®Google Scholar
• Griesser J, Hetényi G, Moser M, et al. Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm. 2017;520(1):267–274.
   PubMedGoogle Scholar
• Ijaz M, Bonengel S, Zupančič O, et al. Development of oral self nano-emulsifying delivery system(s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions. Expert Opin Drug Deliv. 2016;13(7):923–929.
   PubMed Web of Science ®Google Scholar
• Ristroph KD, Prud’homme RK. Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207–4237.
   PubMed Web of Science ®Google Scholar
• Stella VJ. Prodrugs: some thoughts and current issues. J Pharm Sci. 2010;99(12):4755–4765.
   PubMed Web of Science ®Google Scholar
• Noh G, Keum T, Bashyal S, et al. Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals. J Pharm Invest. 2022;52(1):75–93.
   Web of Science ®Google Scholar
• Miller JM, Dahan A, Gupta D, et al. Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir. Mol Pharm. 2010;7(4):1223–1234.
   PubMedGoogle Scholar
• Zhou H, Lengsfeld C, Claffey DJ, et al. Hydrophobic ion pairing of isoniazid using a prodrug approach. J Pharm Sci. 2002;91(6):1502–1511.
   PubMed Web of Science ®Google Scholar
• Wiest J, Saedtler M, Balk A, et al. Mapping the pharmaceutical design space by amorphous ionic liquid strategies. J Control Release. 2017;268:314–322.
   PubMed Web of Science ®Google Scholar
• Yang T, Hussain A, Bai S, et al. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin. J Control Release. 2006;115(3):289–297.
   PubMed Web of Science ®Google Scholar
• Leichner C, Menzel C, Laffleur F, et al. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS. Int J Pharm. 2017;530(1–2):346–353.
   PubMedGoogle Scholar
• Choi SH, Park TG. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Int J Pharm. 2000;203(1):193–202.
   PubMedGoogle Scholar
• Takács-Novák K, Szász G. Ion-Pair Partition of Quaternary Ammonium Drugs: the Influence of Counter Ions of Different Lipophilicity, Size, and Flexibility. Pharm Res. 1999;16(10):1633–1638.
   PubMed Web of Science ®Google Scholar
• Nazir I, Ghezzi M, Asim MH, et al. Self-emulsifying drug delivery systems: about the fate of hydrophobic ion pairs on a phospholipid bilayer %. J Journal of Molecular Liquids. 312 (2020); DOI:10.1016/j.molliq.2020.113454.
   PubMed Web of Science ®Google Scholar
• Griffin BT, Kuentz M, Vertzoni M, et al. Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate. Eur J Pharm Biopharm. 2014;86(3):427–437.
   PubMed Web of Science ®Google Scholar
• Shahzadi I, Nazir I, Nhu Quynh Phan T, et al. About the impact of superassociation of hydrophobic ion pairs on membrane permeability. Eur J Pharm Biopharm. 2020;151:1–8.
   PubMed Web of Science ®Google Scholar
• Jalil A, Asim MH, Nazir I, et al. Self-emulsifying drug delivery systems containing hydrophobic ion pairs of polymyxin B and agaric acid: a decisive strategy for enhanced antimicrobial activity. J Mol Liq. 2020;311:113298.
   Web of Science ®Google Scholar
• Hetényi G, Griesser J, Fontana S, et al. Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patients. Nanomedicine. 2018;13(7):717–732.
   PubMed Web of Science ®Google Scholar
• Hetényi G, Griesser J, Moser M, et al. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017;523(1):357–365.
   PubMed Web of Science ®Google Scholar
• Zupančič O, Partenhauser A, Lam HT, et al. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin. Eur J Pharm Sci. 2016;81:129–136.
   PubMed Web of Science ®Google Scholar
• Liu J, Hirschberg C, Fanø M, et al. Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis. Eur J Pharm Sci. 2020;147:105272.
   PubMed Web of Science ®Google Scholar
• Karamanidou T, Karidi K, Bourganis V, et al. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm. 2015;97:223–229.
   PubMed Web of Science ®Google Scholar
• Hintzen F, Perera G, Hauptstein S, et al. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm. 2014;472(1–2):20–26.
   PubMed Web of Science ®Google Scholar
• Zupančič O, Leonaviciute G, Lam HT, et al. Development and in vitro evaluation of an oral SEDDS for desmopressin. Drug Deliv. 2016;23(6):2074–2083.
   PubMed Web of Science ®Google Scholar
• Li F, Hu R, Wang B, et al. Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake. Acta Pharm Sin B. 2017;7(3):353–360.
   PubMed Web of Science ®Google Scholar
• Lechanteur A, Das Neves J, Sarmento B. The role of mucus in cell-based models used to screen mucosal drug delivery. Adv Drug Deliv Rev. 2018;124:50–63.
   PubMed Web of Science ®Google Scholar
• Boegh M, García-Díaz M, Müllertz A, et al. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation. Eur J Pharm Biopharm. 2015;95:136–143.
   PubMed Web of Science ®Google Scholar
• Abdulkarim M, Sharma PK, Gumbleton M. Self-emulsifying drug delivery system: mucus permeation and innovative quantification technologies. Adv Drug Deliv Rev. 2019;142:62–74.
   PubMed Web of Science ®Google Scholar
• Boegh M, Nielsen HM. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol. 2015;116(3):179–186.
   PubMed Web of Science ®Google Scholar
• Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61(2):75–85.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Bernkop-Schnürch A. Strategies for improving mucosal drug delivery. Nanomedicine. 2013;8(12):2061–2075.
   PubMed Web of Science ®Google Scholar
• Crater JS, Carrier RL. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol Biosci. 2010;10(12):1473–1483.
   PubMed Web of Science ®Google Scholar
• Pereira de Sousa I, Cattoz B, Wilcox MD, et al. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Eur J Pharm Biopharm. 2015;97:257–264.
   PubMed Web of Science ®Google Scholar
• Rossi S, Vigani B, Sandri G, et al. Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles. Expert Opin Drug Deliv. 2019;16(8):777–781.
   PubMed Web of Science ®Google Scholar
• Mahmood A, Bernkop-Schnürch A. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91–101.
   PubMed Web of Science ®Google Scholar
• Maisel K, Reddy M, Xu Q, et al. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. Nanomedicine. 2016;11(11):1337–1343.
   PubMed Web of Science ®Google Scholar
• Veeravalli V, Cheruvu HS, Srivastava P, et al. Three-dimensional aspects of formulation excipients in drug discovery: a critical assessment on orphan excipients, matrix effects and drug interactions. J Pharm Anal. 2020;10(6):522–531.
   PubMed Web of Science ®Google Scholar
• Friedl H, Dünnhaupt S, Hintzen F, et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci. 2013;102(12):4406–4413.
   PubMed Web of Science ®Google Scholar
• Lam HT, Le N-MN, Phan TNQ, et al. Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase. Eur J Pharm Sci. 2020;162:105658.
   PubMed Web of Science ®Google Scholar
• Griesser J, Hetényi G, Kadas H, et al. Self-emulsifying peptide drug delivery systems: how to make them highly mucus permeating. Int J Pharm. 2018;538(1):159–166.
   PubMedGoogle Scholar
• Rohrer J, Partenhauser A, Hauptstein S, et al. Mucus permeating thiolated self-emulsifying drug delivery systems. Eur J Pharm Biopharm. 2016;98:90–97.
   PubMed Web of Science ®Google Scholar
• Zupančič O, Rohrer J, Thanh Lam H, et al. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm. 2017;43(10):1694–1702.
   PubMed Web of Science ®Google Scholar
• Menzel C, Holzeisen T, Laffleur F, et al. In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide. J Control Release. 2018;277:165–172.
   PubMed Web of Science ®Google Scholar
• Asfour MH, Kassem AA, Salama A, et al. Hydrophobic ion pair loaded self-emulsifying drug delivery system (SEDDS): a novel oral drug delivery approach of cromolyn sodium for management of bronchial asthma. Int J Pharm. 2020;585:119494.
   PubMed Web of Science ®Google Scholar
• Zaichik S, Steinbring C, Caliskan C, et al. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration. Int J Pharm. 2019;554:125–133.
   PubMedGoogle Scholar
• Nazir I, Ghezzi M, Asim MH, et al. Self-emulsifying drug delivery systems: about the fate of hydrophobic ion pairs on a phospholipid bilayer. J Mol Liq. 2020;312:113382.
   Web of Science ®Google Scholar
• Phan TNQ, Le-Vinh B, Efiana NA, et al. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction? J Drug Target. 2019;27(9):1017–1024.
   PubMed Web of Science ®Google Scholar
• Lee S-J, Schlesinger PH, Wickline SA, et al. Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers. Soft Matter. 2012;8(26):7024–7035.
   Web of Science ®Google Scholar
• Orive G, Gascón AR, Hernández RM, et al. Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol Sci. 2004;25(7):382–387.
   PubMed Web of Science ®Google Scholar
• Ruddaraju LK, Pammi SVN, Guntuku GS, et al. A review on anti-bacterials to combat resistance: from ancient era of plants and metals to present and future perspectives of green nano technological combinations. Asian J Pharm Sci. 2020;15(1):42–59.
   PubMed Web of Science ®Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602.
   PubMed Web of Science ®Google Scholar
• Ndayishimiye J, Popat A, Blaskovich M, et al. Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides. J Control Release. 2020;324:728–749.
   PubMed Web of Science ®Google Scholar
• Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today. 2010;15(21):958–965.
   PubMed Web of Science ®Google Scholar
• Li P, Nielsen HM, Müllertz A. Oral delivery of peptides and proteins using lipid-based drug delivery systems. Expert Opin Drug Deliv. 2012;9(10):1289–1304.
   PubMed Web of Science ®Google Scholar
• Zaichik S, Steinbring C, Caliskan C, et al. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration. Int J Pharm. 2019;554:125–133.
   PubMedGoogle Scholar
• Su LC, Xie Z, Zhang Y, et al. Study on the antimicrobial properties of citrate-based biodegradable polymers. Front Bioeng Biotechnol. 2014;2:23.
   PubMedGoogle Scholar
• Shahzadi I, Dizdarević A, Efiana NA, et al. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): key to enhanced mucus permeation. J Colloid Interface Sci. 2018;531:253–260.
   PubMed Web of Science ®Google Scholar
• Hanna E, Rémuzat C, Auquier P, et al. Gene therapies development: slow progress and promising prospect. J Mark Access Health Policy. 2017;5(1):1265293.
   PubMedGoogle Scholar
• Alhakamy NA, Curiel DT, Berkland CJ. The era of gene therapy: from preclinical development to clinical application. Drug Discov Today. 2021;26(7):1602–1619.
   PubMed Web of Science ®Google Scholar
• Baig MMFA, Zhang C, Akhtar MF, et al. The effective transfection of a low dose of negatively charged drug-loaded DNA-nanocarriers into cancer cells via scavenger receptors. J Pharm Anal. 2021;11(2):174–182.
   PubMed Web of Science ®Google Scholar
• Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. 2005;7(1):E61–E77.
   PubMed Web of Science ®Google Scholar
• Loretz B, Föger F, Werle M, et al. Oral gene delivery: strategies to improve stability of pDNA towards intestinal digestion. J Drug Target. 2006;14(5):311–319.
   PubMed Web of Science ®Google Scholar
• Farris E, Sanderfer K, Lampe A, et al. Oral non-viral gene delivery for applications in DNA Vaccination and gene therapy. Curr Opin Biomed Eng. 2018;7:51–57.
   PubMedGoogle Scholar
• Griesser J, Hetényi G, Federer C, et al. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: a potent gene delivery model for causal treatment of cystic fibrosis. Int J Pharm. 2019;557:124–134.
   PubMedGoogle Scholar
• Chamieh J, Domènech Tarrat A, Doudou C, et al. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis. Int J Pharm. 2019;559:228–234.
   PubMedGoogle Scholar
• Bonengel S, Jelkmann M, Abdulkarim M, et al. Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs. J Control Release. 2018;273:21–29.
   PubMed Web of Science ®Google Scholar
• Phan TNQ, Ismail R, Le-Vinh B, et al. The effect of counterions in hydrophobic ion pairs on oral bioavailability of exenatide. ACS Biomater Sci Eng. 2020;6(9):5032–5039.
   PubMed Web of Science ®Google Scholar
• Soltani Y, Goodarzi N, Mahjub R. Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin. Drug Dev Ind Pharm. 2017;43(11):1899–1907.
   PubMed Web of Science ®Google Scholar
• Pagels RF, Prud’homme RK. Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics. J Control Release. 2015;219:519–535.
   PubMed Web of Science ®Google Scholar
• Li M, Du C, Guo N, et al. Composition design and medical application of liposomes. Eur J Med Chem. 2019;164:640–653.
   PubMed Web of Science ®Google Scholar
• Kontogiannidou E, Meikopoulos T, Gika H, et al. In vitro evaluation of self-nano-emulsifying drug delivery Systems (SNEDDS) containing room temperature ionic liquids (RTILs) for the oral delivery of amphotericin B. Pharmaceutics. 2020;12(8):699.
   PubMed Web of Science ®Google Scholar
• Kaur G, Kumar H, Singla M. Diverse applications of ionic liquids: a comprehensive review. J Mol Liq. 2022;351:118556.
   Web of Science ®Google Scholar
• Wolf JD, Kurpiers M, Baus RA, et al. Characterization of an amino acid based biodegradable surfactant facilitating the incorporation of DNA into lipophilic delivery systems. J Colloid Interface Sci. 2020;566:234–241.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Dorkoosh FA, Rafiee-Tehrani M, et al. Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release. J Microencapsul. 2015;32(4):401–407.
   PubMed Web of Science ®Google Scholar
• Gosangari S, Dyakonov T. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations. Pharm Dev Technol. 2013;18(2):475–480.
   PubMed Web of Science ®Google Scholar